Stockreport

Beam Therapeutics Announces Transition of Chief Financial Officer

Beam Therapeutics Inc.  (BEAM) 
PDF CAMBRIDGE, Mass., July 15, 2024 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base [Read more]